Skip to main content
. 2021 Dec 30;29(1):163–172. doi: 10.3390/curroncol29010015

Table 2.

Response evaluation.

Treatment Response Number of Patients
(N = 21)
Patients (%) Number of Patients Excluding Those with SCLC a (N = 18) Patients Excluding Those with SCLC a (%)
Not evaluated 5 23.8 3 16.7
Evaluated 16 - 15 -
Complete response 11 52.4 10 55.6
Partial response 3 14.3 3 16.7
Treatment failure 2 9.5 2 11

a SCLC, small cell lung cancer.